Peer-reviewed research shows that Gro can improve mental and physical health and wellbeing.
Summers, C., Caleyachetty, R. (2020). Supporting mental health and resilience during COVID-19: 8-week outcomes of a mindfulness based digital intervention to support vulnerable and at-risk patients. Pending publication.
Saslow, L. R., Summers, C., Aikens, J. E., & Unwin, D. J. (2018). Outcomes of a digitally delivered low-carbohydrate type 2 diabetes self-management program: 1-year results of a single-arm longitudinal study. JMIR diabetes, 3(3), e12
In collaboration with researchers and clinicians at St Claraspital, the primary purpose of this multi-centre, binational clinical trial is to evaluate the therapeutic potential of the platform on disease-associated parameters in MDD with or without obesity over 6 months.
Secondary purposes include exploring the impact of the platform on blood lipids, uric acid, incretins, plasma BDNF levels, cytokines, gut microbiota composition, markers of leaky gut, metabolic markers, metabolomics, weight, body composition and liver fat fraction, psychometry- brain network activity, hypothalamic-pituitary-adrenal, HPA axis, gastrointestinal tolerance.
Our study with King's College London, funded by the The Association for the Study of Obesity, is evaluating the feasibility of the Gro Health app and obesity program in a Tier 3 and Tier 4 obesity setting in London.
Our study with Imperial College London is evaluating the feasibility of the Gro Health app and obesity program in a Tier 3 and Tier 4 obesity setting in London.
An international study in partnership with the University of British Columbia and Institute of Personalized Nutrition will look at the feasibility of using Gro to deliver personalized nutrition to patients across Canada. The study, led by Professor Jonathan Little, will assess the use of the Gro app on a number of parameters and will collect physician and patient data throughout the course of the study
Start your journey to better health